Hospitals are experiencing shortages of sterile water used to reconstitute certain medications for injection, according to a new factsheet by the American Society of Health-System Pharmacists and University of Utah Drug Information Service, which includes strategies to help pharmacists and organizations mitigate these shortages. “Without a consistent supply of SW for injection, health care personnel need to decide between selecting other therapies as treatments or using a sterile liquid other than SW for injection despite a lack of definite information about the effects on drug stability and compatibility,” the factsheet notes. “The consequences of using a sterile liquid not listed in product labeling to reconstitute medication vials may include poor dissolution of the powder, precipitation, or deactivation of the active pharmaceutical ingredient before further dilution or administration.” For more on the SW shortages, see the Food and Drug Administration and ASHP drug shortage databases.

Related News Articles

Headline
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a…
Headline
The Department of Commerce Sept. 24 released a notice seeking public comment on an investigation it launched Sept. 2 on imports of personal protective…
Headline
The Food and Drug Administration has identified a Class I recall of certain Olympus ViziShot 2 FLEX Needles due to a possible patient safety issue caused by a…
Headline
The White House Sept. 5 issued an executive order modifying the scope of reciprocal tariffs announced in April to establish a framework of trade deals with…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…